Sunday, June 28, 2015

Dr. John Leonard on R-Squared

Before I get to  Lymphoma stuff, I need to comment on this first:

The clothing store Old Navy has an online catalog, and they divide the clothes into the usual categories: men, women, children; pants, shirts, shoes; whatever. But then they divide things into certain "styles," too, and I have an objection to one: the "blogger" style.

You can see a sample here of what kind of clothes they think bloggers wear. I think the slip-on canvas shoes actually look kind of comfortable (though they do remind me a lot of the espadrilles my mother wore in the 70's). But I want to make it very, very clear right now: I will never, ever, wear a straw fedora. Also, there is way too much "skinny" clothing in this collection. Honestly, I don't know too many skinny bloggers. We actually tend to sit around quite a bit. It's not a lifestyle that results in "skinny" anything, except maybe "skinny lattes" when we're fooling ourselves that they are healthier.

Apparently, "comfort" is the goal.

(Though, that doesn't explain the fedora.....)


On to Lymphoma stuff:

The Lymphoma Program at NewYork-Presbyterian Hospital/Weill Cornell Medical College publishes a blog (no word on whether their blogger wears canvas slip-on shoes) called "New Developments in Lymphoma." I've linked to them before, though it's been a while.

Their most recent post is pretty interesting:

Dr. John Leonard, who teaches at the Cornell Medical College, gives a brief overview of recent studies of Lenalidomide + Rituxan, also known as R-Squared (Lenalidomide = Revlimid).

He discusses the AUGMENT trial that was reported on at ASCO, and mentions a couple of other trials that have moved onto phase III (I think these were the "promising" ones I wrote about a few weeks ago.

You can see the video here. It's pretty short, and doesn't have time to get into much detail, but if nothing else, it's a good excuse to mention the Cornell blog again, and to encourage you to read  around in it.

(And, of course, a good excuse to reconsider my wardrobe.)

No comments: